Levrett Plc (LON:LVRT) CEO Pascal Hughes talks to DirectorsTalk about the appointment of new broker Whitman Howard, insights from the San Francisco biotech conference and potential acquisition.
Mr Hughes is a financier, investor and entrepreneur. He previously worked in Investment Banking in the City of London for close to 20 years most recently as a Managing Director in Fixed Income, Currencies and Commodities at UBS bank. Prior to that he was a Managing Director in Global Banking and Markets at HSBC. He left UBS to become an active private investor and advisor to start-up companies in a variety of different business areas from financial technologies to oil field services. During this period he has been involved in developing businesses and advising on acquisition and turn round strategy. Pascal has a B.A (Hons) in Accounting and Finance from Dublin City University, and an MSc. in Financial Economics from Queens University Belfast.
Levrett plc is a special purpose acquisition company formed to acquire realisable and/or developed commercial technologies focused in the Pharmaceutical and Biotechnology sector.The Company draws on its expertise in the Pharmaceutical and Biotechnology sector to assess different propositions and initiate discussions via market contacts and professional advisers. In selecting acquisition opportunities to review, the Board will focus on entities that are available at attractive valuations and hold opportunities to unlock embedded value. Following completion of an acquisition, the objective will be to operate the acquired business and implement an operating strategy with a view to generating value for its shareholders through operational and product development as well as possible complimentary acquisitions.
